The DecisionDx-Melanoma 31-GEP test recently released top data from the largest prospective GEP study. The study was ...

Sequencing Cryotherapy, Topicals, and PDT in Actinic Keratosis. Bhatia said comprehensive management of actinic keratosis has ...

Hsiao noted the options are adalimumab, a tumor necrosis factor α inhibitor; secukinumab, an IL-17A inhibitor; and ...

In a retrospective study of 393 patients, 51.9% had at least 1 abnormal LFT during follow-up, but only 1.1% had elevations ...

Validated screening tools can help, but Friedman said several straightforward questions can also be incorporated into routine visits. He asks patients about prolonged stiffness at rest that improves ...

Ahmad Naim, MD, discussed clinician education, long-term data, and what is next in alopecia areata, HS, and psoriasis.

Trotter said dermatologists should pay attention to locally advanced and metastatic cutaneous squamous cell carcinoma (cSCC).

The second day of Fall Clinical 2026 brought new psoriasis data on ixekizumab plus tirzepatide and 2-year icotrokinra results ...

She described the patient consult as the starting point for aesthetic care. It covers the patient’s history, motivation for seeking treatment, prior aesthetic procedures, keloid history, and herpes ...

The recent FDA approval of remibrutinib (Rhapsido) for symptomatic dermographism (SD) gives clinicians an on-label option for a condition long managed with off-label therapies, Raj Chovatiya, MD, PhD, ...

For a patient with atopic dermatitis who is ready for systemic therapy, the first priority is getting them on one, Raj Chovatiya, MD, PhD, MSCI, told Dermatology Times in an interview at. “There ...

Shannon Trotter, DO, discusses augmented intelligence in skin cancer detection, the approval of remibrutinib for symptomatic ...